David Lebeaux

11.1k total citations · 3 hit papers
106 papers, 5.1k citations indexed

About

David Lebeaux is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, David Lebeaux has authored 106 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 29 papers in Infectious Diseases and 20 papers in Microbiology. Recurrent topics in David Lebeaux's work include Infective Endocarditis Diagnosis and Management (20 papers), Actinomycetales infections and treatment (20 papers) and Central Venous Catheters and Hemodialysis (17 papers). David Lebeaux is often cited by papers focused on Infective Endocarditis Diagnosis and Management (20 papers), Actinomycetales infections and treatment (20 papers) and Central Venous Catheters and Hemodialysis (17 papers). David Lebeaux collaborates with scholars based in France, United States and Belgium. David Lebeaux's co-authors include Christophe Beloin, Jean‐Marc Ghigo, Ashwini Chauhan, Olaya Rendueles, Steven Pinker, D. Sène, Olivier Lortholary, Claus Moser, Veronika Holá and Antonio Oliver and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

David Lebeaux

97 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics

2014 962 citations David Lebeaux, Jean‐Marc Ghigo et al. profile →
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

2015 580 citations David Lebeaux et al. profile →
How do I manage nocardiosis?

2021 106 citations David Lebeaux, Julien Coussement et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Lebeaux France	33	1.8k	997	966	621	547	106	5.1k
Deborah A. Williamson Australia	41	1.1k 0.6×	2.1k 2.1×	1.7k 1.8×	901 1.5×	775 1.4×	274	6.3k
Brigitte König Germany	28	714 0.4×	815 0.8×	680 0.7×	164 0.3×	142 0.3×	100	2.5k
Savitri Sharma India	47	1.1k 0.6×	827 0.8×	935 1.0×	195 0.3×	241 0.4×	328	7.7k
Barbara A. Brown United States	46	591 0.3×	2.7k 2.7×	4.2k 4.3×	149 0.2×	405 0.7×	87	5.8k
Frédéric Laurent France	49	3.1k 1.8×	4.0k 4.1×	1.6k 1.6×	745 1.2×	669 1.2×	344	8.7k
Tristan Ferry France	41	1.0k 0.6×	2.0k 2.0×	1.2k 1.3×	511 0.8×	190 0.3×	270	5.2k
R.J. Gibbons United States	62	2.8k 1.6×	1.1k 1.1×	1.6k 1.6×	863 1.4×	75 0.1×	145	12.2k
Eija Könönen Finland	42	1.3k 0.7×	678 0.7×	812 0.8×	455 0.7×	90 0.2×	167	6.5k
Daniel Lew Switzerland	41	1.2k 0.6×	2.1k 2.1×	2.1k 2.2×	273 0.4×	474 0.9×	102	7.5k
Kathryn Harris United Kingdom	30	853 0.5×	774 0.8×	1.2k 1.3×	512 0.8×	167 0.3×	74	3.4k

Countries citing papers authored by David Lebeaux

Since Specialization

Citations

This map shows the geographic impact of David Lebeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lebeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lebeaux more than expected).

Fields of papers citing papers by David Lebeaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lebeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lebeaux. The network helps show where David Lebeaux may publish in the future.

Co-authorship network of co-authors of David Lebeaux

This figure shows the co-authorship network connecting the top 25 collaborators of David Lebeaux. A scholar is included among the top collaborators of David Lebeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lebeaux. David Lebeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dinh, Aurélien, François Barbier, Vincent Cattoir, et al.. (2025). Actualisation des recommandations de prise en charge des pneumonies aiguës communautaires chez l’adulte par la Société de pathologie infectieuse de langue française (SPILF) et la Société de pneumologie de langue française (SPLF). Avec le soutien de la Société de réanimation de langue française, (SRLF), de la Société française de microbiologie (SFM), de la Société française de radiologie (SFR) et de la Société française de médecine d’urgence (SFMU). Revue des Maladies Respiratoires. 42(3). 168–186.

Dinh, Aurélien, François Barbier, Jean‐Pierre Bédos, et al.. (2025). Update of guidelines for management of Community Acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF). Respiratory Medicine and Research. 87. 101161–101161.

Jacquier, Hervé, et al.. (2025). Analysis of two Nocardia brasiliensis class A β-lactamases (BRA-1 and BRS-1) and related resistance to β-lactam antibiotics. Journal of Global Antimicrobial Resistance. 42. 135–141.

Gras, Emmanuelle, et al.. (2023). Incidence of and risk factors for local complications of peripheral venous catheters in patients older than 70 years: Empirical research quantitative. Journal of Clinical Nursing. 32(15-16). 5000–5009. 4 indexed citations

Josse, Jérôme, David Pérez-Pascual, Jason Tasse, et al.. (2023). Analysis of In-Patient Evolution of Escherichia coli Reveals Potential Links to Relapse of Bone and Joint Infections. The Journal of Infectious Diseases. 229(5). 1546–1556. 2 indexed citations

Gras, Emmanuelle, Benjamin Kably, Agnés Lillo‐Le Louët, et al.. (2023). Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin. Infection. 52(2). 557–566.

Serris, Alexandra, Julien Coussement, B. Pilmis, et al.. (2023). New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting. Transplant International. 36. 11859–11859. 2 indexed citations

Gras, Emmanuelle, Emmanuelle Bergeron, Mathilde Pugès, et al.. (2022). Identification of Streptomyces spp. in a Clinical Sample: Always Contamination? Results of a French Retrospective Study. Open Forum Infectious Diseases. 9(7). ofac271–ofac271. 1 indexed citations

Rolland, Simon, Najiby Kassis‐Chikhani, Édouard Auclin, et al.. (2022). TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?. European Journal of Clinical Microbiology & Infectious Diseases. 42(2). 161–168. 1 indexed citations

10.

Bonnet, É., C. Chambrier, Alexandre Charmillon, et al.. (2021). Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: When and how to proceed? Guidelines for clinical practice 2020. Infectious Diseases Now. 51(3). 236–246. 17 indexed citations

11.

Lebeaux, David, Maia Merabishvili, Éric Caudron, et al.. (2021). A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient. Viruses. 13(1). 60–60. 88 indexed citations

12.

Gauzit, R., Bernard Castan, É. Bonnet, et al.. (2021). Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 51(2). 114–139. 20 indexed citations

13.

Vilfaillot, Aurélie, et al.. (2021). Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales. European Journal of Clinical Microbiology & Infectious Diseases. 41(1). 71–77. 11 indexed citations

14.

Dubert, Marie, S. Diamantis, Anne‐Laure Roux, et al.. (2020). Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer. Infection. 49(2). 345–348. 4 indexed citations

15.

Lebeaux, David, Núria Fernández-Hidalgo, Ashwini Chauhan, et al.. (2013). Management of infections related to totally implantable venous-access ports: challenges and perspectives. The Lancet Infectious Diseases. 14(2). 146–159. 127 indexed citations

16.

Chauhan, Ashwini, David Lebeaux, Jean‐Marc Ghigo, & Christophe Beloin. (2012). Full and Broad-Spectrum In Vivo Eradication of Catheter-Associated Biofilms Using Gentamicin-EDTA Antibiotic Lock Therapy. Antimicrobial Agents and Chemotherapy. 56(12). 6310–6318. 79 indexed citations

17.

Lortholary, Olivier, Caroline Charlier, David Lebeaux, Marc Lecuit, & Paul‐Henri Consigny. (2012). Fungal Infections in Immunocompromised Travelers. Clinical Infectious Diseases. 56(6). 861–869. 24 indexed citations

18.

Barbier, François, David Lebeaux, David Hernández, et al.. (2010). High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 66(1). 29–36. 78 indexed citations

19.

Lebeaux, David. (1988). Language acquisition and the form of the grammar : a disseration. University Microfilms International eBooks. 12 indexed citations

20.

Lebeaux, David. (1984). Anaphoric Binding and the Definition of PRO. Scholarworks (University of Massachusetts Amherst). 14(1). 16. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact